Medytox Solutions (MMMS) 2.0100 $MMMS Medytox Solutions,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medytox Solutions (MMMS) 2.0100 $MMMS

Medytox Solutions, Inc. Announces New Board Members
Marketwired - Thu Aug 13, 10:00AM CDT
Medytox Solutions, Inc. announces the election of two new board members who boast years of professional leadership in corporate governance, financial services, company restructuring, and healthcare. Michael L. Goldberg, managing director of Monarch Capital, LLC, and Robert Lee, managing partner of Sheffield Investment Partners, joined returning board members Christopher E. Diamantis, chairman and CEO of Integrated Financial Settlements, Inc.; Benjamin Frank, a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government; and Seamus Lagan, CEO of Medytox Solutions, Inc. The election took place at the annual stockholders' meeting of Medytox Solutions, Inc. on August 6, 2015.

July Brings Winning Streak Of Massive Cash Jackpots To Table Mountain Casino Players Club Members
PR Newswire - Mon Jul 20, 7:13PM CDT
Reel luck and huge winnings have Table Mountain Casino Club Members getting their win on as yet another random Massive Cash Jackpot paid out again--the third one in a string of BIG jackpots to hit.

CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price
GlobeNewswire - Fri Jun 05, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company", announced today that it received a letter from The NASDAQ Stock Market LLC ("Nasdaq" stating that the bid price of the Company's common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2).
CLRX: 0.67 (-0.02)

InsiderInsights.com Daily Round Up 6/1/15: Unwired Planet, GoPro, Impac Mortgage Holdings And Halcon Resources
InsiderInsights - at Seeking Alpha - Tue Jun 02, 12:53PM CDT

UCP: 8.08 (+0.35), GPRO: 32.42 (-1.46), HK: 0.97 (-0.07), CUBI: 25.08 (+0.32), ASPS: 30.19 (-0.74), ADMS: 19.93 (+0.50), LLY: 81.80 (+0.96), GOOG: 625.77 (+4.42), AMH: 15.67 (+0.11), CME: 94.48 (+1.01), LBF: 7.98 (+0.03), NVAX: 10.00 (-0.10), WRI: 31.44 (+0.59), AXTA: 28.25 (-0.28), IMH: 16.83 (+0.78), SPLK: 59.65 (-0.41), UPIP: 0.80 (-0.02), CMLS: 1.18 (-0.06)

Table Mountain Casino's Massive Cash Jackpot Pays Yet Another Lucky Winner
PR Newswire - Mon Jun 01, 6:32PM CDT
Table Mountain Casino's Lucky Club member, Gurdial of Fresno, visited his favorite casino, Table Mountain, and left with a mountain of money! The popular Massive Cash jackpot randomly paid out on the machine he was playing, showering him with $100,604.82 in cold hard cash!

CollabRx Receives Notice From Nasdaq on Change of Control
GlobeNewswire - Wed Apr 29, 6:01AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" or "the Company", today announced that it had received notice from The NASDAQ Stock Market LLC ("Nasdaq" that the Company's proposed transaction with Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" when completed would constitute a business combination that results in a "change of control" as that term is defined in Nasdaq Listing Rule 5110(a). Accordingly, the post-transaction entity would be required to successfully complete the Nasdaq listing application process and satisfy all criteria for initial listing on Nasdaq.
CLRX: 0.67 (-0.02)

CollabRx and Medytox Solutions Sign Definitive Merger Agreement
GlobeNewswire - Thu Apr 16, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions.
CLRX: 0.67 (-0.02)

Medytox Solutions Signs Definitive Merger Agreement With CollabRx
GlobeNewswire - Thu Apr 16, 6:00AM CDT
Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox" and CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" today announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions.
CLRX: 0.67 (-0.02)

Integrated Healthcare Company, Medytox Solutions, Inc., Names New COO
Marketwired - Wed Feb 18, 10:00AM CST
Medytox Solutions, Inc. (OTCBB: MMMS), which owns and operates clinical laboratories and healthcare technology companies, announced today that it named Samuel R. Mitchell, Jr., chief operating officer. As COO, Mr. Mitchell will work to streamline performance throughout the Medytox family of companies headquartered in West Palm Beach. He will also oversee quarterly and annual financial goal management.

CollabRx announces non-binding letter of intent for proposed business combination with Medytox Solutions
M2 - Fri Jan 23, 8:03PM CST
Medical information company CollabRx (NasdaqCM:CLRX) reported on Thursday the execution of a non-binding letter of intent to negotiate a potential business combination with Medytox Solutions (OTCBB:MMMS).
CLRX: 0.67 (-0.02)

CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination
Marketwired - Thu Jan 22, 5:30AM CST
CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox" have entered into a non-binding letter of intent to negotiate a potential business combination. Also, CollabRx and Medytox announced that they have entered into agreements that would secure funding needed by CollabRx to continue to operate while the parties negotiate a potential business combination. The potential business combination is subject to, among other things, due diligence, the execution of a definitive agreement, necessary Board of Directors and stockholder approvals and other customary conditions.
CLRX: 0.67 (-0.02)

Medytox Diagnostics' International Technologies awarded the New York State Department's Health Clinical Laboratory permit
M2 - Thu Jan 08, 4:53AM CST
Medytox Diagnostics stated on Wednesday that its New Jersey-based laboratory, International Technologies, has been certified with a Clinical Laboratory Permit by the New York State Department of Health.

Medytox Diagnostics Awarded License to Begin Lab Testing in New York State
Marketwired - Wed Jan 07, 10:06AM CST
The New York State Department of Health awarded Medytox Diagnostics, Inc.'s New Jersey-based laboratory, International Technologies, LLC, with a Clinical Laboratory Permit that allows the lab to begin servicing clients throughout New York State with a full continuum of laboratory services, including sophisticated drug screening. Medytox Diagnostics, a subsidiary of Medytox Solutions, Inc. (OTCBB: MMMS), has carved a niche serving the drug testing needs of substance abuse facilities and pain management practices at its New Jersey lab and its network of laboratories nationwide.

CORRECTION - Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Tue Dec 30, 9:00AM CST
In the news release, "Medytox Billing Subsidiary Expands Patient Relations Department," issued Wednesday, December 24, 2014 by Medytox Solutions, Inc. (OTCBB: MMMS), we are advised by the company that the fourth paragraph should read "William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories" rather than "William DePond, M.D., COO of Medytox Solutions, Inc., and CEO of Medytox laboratories" as originally issued. Complete corrected text follows.

Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Wed Dec 24, 9:30AM CST
Medical Billing Choices, Inc., a subsidiary of Medytox Solutions, Inc., has created a new Patient Relations department to assist the growing number of patients served through Medytox-owned laboratories with the patient responsibility portion of claims generated for services. Medytox's network of laboratories provides a full continuum of laboratory and clinical testing services, including sophisticated drug screening, on behalf of physicians and facilities nationwide.

Fast-Growing Chain of Labs, Medytox Diagnostics, Announces CEO of Laboratories
Marketwired - Wed Dec 17, 10:21AM CST
Medytox Diagnostics, Inc., which owns and operates half a dozen clinical laboratories throughout the U.S., announced today it named William DePond, M.D., CEO of Medytox laboratories. In his role, Dr. DePond will oversee the company's expanding network of toxicology labs that specialize in drug screening and analysis for substance abuse facilities and the ongoing drug screening required for patients of pain management physicians.

Florida-Based Health Technology Company Hires Specialized PR and Marketing Firm
Marketwired - Wed Nov 19, 2:34PM CST
The Weinbach Group, a marketing communications firm with expertise in healthcare-related public relations and advertising, announced today that Medytox Solutions, Inc. (OTCBB: MMMS) selected the Miami public relations firm to build recognition for the West Palm Beach-based health technology company. Medytox, which has recently completed a number of strategic acquisitions, anticipates continued M&A activity into 2015. It will utilize The Weinbach Group to raise visibility among prospective targets for acquisition, capital sources, and industry decision makers who use services provided by Medytox' family of companies.

Electronic Health Records Developer, Medical Mime, Launches System for Substance Abuse Treatment Centers
Marketwired - Thu Nov 06, 10:44AM CST
Psychiatrists, psychologists, social workers, and other mental health professionals finally have an electronic health record (EHR) system created for their specific practice environments. Healthcare technology company, Medical Mime, announced today the introduction of a new EHR system tailored to therapists working at drug and alcohol treatment centers -- one of the markets Medical Mime's parent company, Medytox Solutions, Inc. (OTCBB: MMMS), serves. The new system was developed to address the wide range of clinical professionals who treat patients with chemical dependencies, many of whom have never used an EHR system before.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading